Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Nephropathy”

269 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 269 results

Not applicableUnknownNCT03547414
What this trial is testing

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

Who this might be right for
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens 110
Not applicableActive Not RecruitingNCT06652100
What this trial is testing

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

Who this might be right for
Acute Kidney Injury
BioPorto Diagnostics 800
Post-approval studies (Phase 4)Study completedNCT00412802
What this trial is testing

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeRenal Failure
French Cardiology Society 67
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT00296400
What this trial is testing

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease

Who this might be right for
Hyperlipidemia
AstraZeneca 237
Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Early research (Phase 1)Looking for participantsNCT07001436
What this trial is testing

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects

Who this might be right for
Renal Insufficiency
Henan Genuine Biotech Co., Ltd. 40
Post-approval studies (Phase 4)WithdrawnNCT02130817
What this trial is testing

Belatacept in Kidney Transplantation of Moderately Sensitized Patients

Who this might be right for
End Stage Renal DiseaseAntibody Mediated Rejection
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT01766154
What this trial is testing

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Insufficiency
Medicure 25
Early research (Phase 1)Study completedNCT02320045
What this trial is testing

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

Who this might be right for
Renal Insufficiency
Intarcia Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT01345656
What this trial is testing

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Who this might be right for
Heart Failure
Bayer 457
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Not applicableLooking for participantsNCT07098351
What this trial is testing

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Who this might be right for
Adverse EventPeritoneal DialysisModerate-to-severe Pruritus+1 more
Guangdong Provincial People's Hospital 93
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Not applicableStudy completedNCT06884462
What this trial is testing

Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients

Who this might be right for
Diabetic Nephropathies
Deraya University 60
Post-approval studies (Phase 4)Study completedNCT00369382
What this trial is testing

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Who this might be right for
Graft RejectionKidney Failure
Wyeth is now a wholly owned subsidiary of Pfizer 121
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Load More Results